Meta-analysis of the efficacy of neoadjuvant immunotherapy combined with radiotherapy and chemotherapy for locally advanced rectal cancer

Figure 4 Subgroup analysis of major pathological response, pathological complete response, and clinical complete response in patients with proficient mismatch repair status. A-C: Forest plot of major pathological response rate risk ratio in the subgroup of patients with proficient mismatch repair (pMMR; A), pathological complete response rate risk ratio in the subgroup of patients with pMMR (B), and clinical complete response rate risk ratio in the subgroup of patients with pMMR (C); D and E: Forest plot of R0 resection (D) and the sphincter preservation (E) rate risk ratio.